Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 22204725

A phase 3 trial of bevacizumab in ovarian cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2011 Dec 29
First author
Perren TJ

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2012 Jan 19;366(3):284
    note
    Source null
    related pmid
    Source null
    relationship
    Erratum in
    url
    Source null
  2. citation
    Nat Rev Cancer. 2012 Jan 24;12(2):83. doi: 10.1038/nrc3213.
    note
    Source null
    related pmid
    22270952
    relationship
    Comment in
  3. citation
    N Engl J Med. 2012 Mar 29;366(13):1256; author reply 1257-8. doi: 10.1056/NEJMc1201044.
    note
    Source null
    related pmid
    22455428
    relationship
    Comment in
  4. citation
    N Engl J Med. 2012 Mar 29;366(13):1257; author reply 1258. doi: 10.1056/NEJMc1201044.
    note
    Source null
    related pmid
    22455430
    relationship
    Comment in

Authors and identifiers

  1. name
    Perren TJ
    type
    Author
  2. name
    Swart AM
    type
    Author
  3. name
    Pfisterer J
    type
    Author
  4. name
    Ledermann JA
    type
    Author
  5. name
    Pujade-Lauraine E
    type
    Author
  6. name
    Kristensen G
    type
    Author
  7. name
    Carey MS
    type
    Author
  8. name
    Beale P
    type
    Author
  9. name
    Cervantes A
    type
    Author
  10. name
    Kurzeder C
    type
    Author
  11. name
    du Bois A
    type
    Author
  12. name
    Sehouli J
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Perren TJ
    type
    Author
  2. name
    Swart AM
    type
    Author
  3. name
    Pfisterer J
    type
    Author
  4. name
    Ledermann JA
    type
    Author
  5. name
    Pujade-Lauraine E
    type
    Author
  6. name
    Kristensen G
    type
    Author
  7. name
    Carey MS
    type
    Author
  8. name
    Beale P
    type
    Author
  9. name
    Cervantes A
    type
    Author
  10. name
    Kurzeder C
    type
    Author
  11. name
    du Bois A
    type
    Author
  12. name
    Sehouli J
    type
    Author
bibliography ids
  1. nci-bib-46324378304e368ae7bdab4f
book metadata
content sha256
73ed400bf3c5a7d295d3bf1bcb5e1464ee38918a8a58f386e50a46448095023c
document type
citation
dois
  1. 10.1056/NEJMoa1103799
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:22204725
immutable id
pubmed:22204725@73ed400bf3c5a7d295d3bf1bcb5e1464ee38918a8a58f386e50a46448095023c
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
26
name
The New England journal of medicine
nlm unique id
0255562
pages
2484-96
volume
365
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2012 Jan 19;366(3):284
    note
    Source null
    related pmid
    Source null
    relationship
    Erratum in
    url
    Source null
  2. citation
    Nat Rev Cancer. 2012 Jan 24;12(2):83. doi: 10.1038/nrc3213.
    note
    Source null
    related pmid
    22270952
    relationship
    Comment in
  3. citation
    N Engl J Med. 2012 Mar 29;366(13):1256; author reply 1257-8. doi: 10.1056/NEJMc1201044.
    note
    Source null
    related pmid
    22455428
    relationship
    Comment in
  4. citation
    N Engl J Med. 2012 Mar 29;366(13):1257; author reply 1258. doi: 10.1056/NEJMc1201044.
    note
    Source null
    related pmid
    22455430
    relationship
    Comment in
outcomes validated
false
pmid
22204725
provenance
batch id
b6284687e167e7da9556
provider
NCBI PubMed ESummary
record sha256
932d6e71b5c54a49ab8c2cc6d4746d0c8e262b91cea8e3a1c31e6fc55fde86e8
response sha256
64d5b7bb63f574c559af2523b779a262267cbc8e8cd02a5b47f4193cc95cabd3
retrieved at
2026-09-09T23:46:45.216259+00:00
publication date
display
2011 Dec 29
precision
day
year
2011
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/22204725/
title
A phase 3 trial of bevacizumab in ovarian cancer.

Preserved source evidence · Not medical advice